Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance

Cefiderocol is a new siderophore-cephalosporin for the treatment of multi-drug resistant Gram-negative pathogens. As a reserve agent, it will and should be used primarily in critically ill patients in the upcoming years. Due to the novelty of the substance little data on the pharmacokinetics in crit...

Descripción completa

Detalles Bibliográficos
Autores principales: König, Christina, Both, Anna, Rohde, Holger, Kluge, Stefan, Frey, Otto R., Röhr, Anka C., Wichmann, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226704/
https://www.ncbi.nlm.nih.gov/pubmed/34071700
http://dx.doi.org/10.3390/antibiotics10060649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226704/
https://www.ncbi.nlm.nih.gov/pubmed/34071700
http://dx.doi.org/10.3390/antibiotics10060649

Ejemplares similares